Date & Location
Friday, September 20, 2024, 7:55 AM - 5:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties - Bone Marrow Transplant, Cardiology, Emergency Medicine, General and Family Practice, Geriatric Medicine, Hematology, Hospice and Palliative Medicine, Hospitalist, Immunotherapy, Infectious Diseases, Integrative Medicine, Internal Medicine, Leukemia, Lymphoma, Medical Oncology, Nurse Practitioner, Nursing, Oncology and Hematology, Pharmacology and Medication Management, Physician Assistant, Pulmonology, Radiation Oncology, Respiratory Therapy, Sleep Medicine, Solid Tumor Oncology, Surgical Oncology, Thoracic Medical Oncology, Thoracic Surgery

Overview

Pulmo-Oncology is an emerging discipline that has great importance to the clinical care of cancer patients. The respiratory system is often impacted by direct cancer involvement as well as by infections and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.

In this multidisciplinary symposium, clinical experts from Memorial Sloan Kettering (MSK) and around the world, will present an up-to-date overview on cutting edge cancer therapies and best practice strategies in the evaluation and management of lung disease. The purpose of this conference is to provide a state-of-the-art, case-based, multidisciplinary curriculum that addresses selected topics relevant to the respiratory health of patients with cancer. View the brochure for additional information. 

The symposium offers participants the choice of attending either in person or virtually and is intended for healthcare professionals in pulmonology, hematology and oncology, and other disciplines involved in the care of cancer patients or who have a special interest in this area.

Objectives
At the conclusion of this symposium, attendees will be able to:

  1. Explain the role of the pulmonologist in diagnosis and management of lung cancer
  2. Identify state of the art treatment strategies for management of lung cancer and check point inhibitor pneumonitis
  3. Implement strategies for diagnosis and management of infectious and non-infectious pulmonary complications of stem cell transplant
  4. Discuss multidisciplinary approach in complex patients.
  5. Explain the diagnosis and clinical significance of pre-existing interstitial lung abnormalities and interstitial lung disease in cancer management

Registration

This symposium offers participants the choice of attending either in person or virtually. In-person registrants will be provided continental breakfast, lunch, and refreshment breaks. Please contact cme@mskcc.org at least one week prior to the course if you have any special dietary requests or require any specific accommodations for joining us onsite.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Registration Rates

  • Physicians (MDs, PhDs, and DOs): $300
  • Advanced Practice Providers: $250
  • Nursing and Other Healthcare Professionals: $150
  • Residents, Fellows, and Students: $100 (non-refundable)
  • Industry Professionals*: $525
  • MSK Employees: Complimentary

For details on our cancellation terms, please review our Cancellation Policy.

*An “industry professional” is defined as any individual, regardless of their profession type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
  • 7.50 credit toward the CME and Self-Assessment of the American Board of Thoracic Surgery’s (ABTS) Maintenance of Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABTS MOC/CC credit.

ANCC CNE Statement

Memorial Sloan Kettering Cancer Center–Nursing Professional Development / Continuing Education is accredited with distinction as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center’s Commission on Accreditation.

8.50 contact hours will be awarded to participants who attend the program in its entirety and complete a program evaluation. Partial credit not awarded.